Impact of the Temporal Relationship Between Atrial Fibrillation and Heart Failure on Prognosis After Ablation

Background:The purpose of this study was to elucidate the effect of the temporal relationship between atrial fibrillation (AF) and heart failure (HF) on clinical outcomes after catheter ablation.Methods and Results:We included 129 consecutive patients with AF and HF who underwent catheter ablation i...

Full description

Saved in:
Bibliographic Details
Published in:Circulation Journal Vol. 84; no. 9; pp. 1467 - 1474
Main Authors: Tsuji, Aki, Masuda, Masaharu, Asai, Mitsutoshi, Iida, Osamu, Okamoto, Shin, Ishihara, Takayuki, Nanto, Kiyonori, Kanda, Takashi, Tsujimura, Takuya, Matsuda, Yasuhiro, Okuno, Shota, Hata, Yosuke, Mano, Toshiaki
Format: Journal Article
Language:English
Published: Japan The Japanese Circulation Society 25-08-2020
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background:The purpose of this study was to elucidate the effect of the temporal relationship between atrial fibrillation (AF) and heart failure (HF) on clinical outcomes after catheter ablation.Methods and Results:We included 129 consecutive patients with AF and HF who underwent catheter ablation in hospital from December 2014 to September 2017. The patients were divided into 2 groups based on the temporal relationship between AF and HF. Group 1 consisted of 42 patients with AF following HF while Group 2 consisted of 87 patients with AF preceding HF or those who developed both of them simultaneously at the timing of first visit to a doctor. The primary endpoint was a composite of death and hospitalization due to HF during a 2-year follow-up. AF recurrence was more common in Group 1 (45% vs. 23%; hazard ratio [HR], 2.49; 95% confidence interval [CI], 1.25–4.94; P=0.009). Death and HF hospitalization were more frequent in Group 1 (19 [45%], 6 [7%] patients, respectively, P<0.0001). After adjustment for several covariates, patients in Group 1 were independently associated with poorer outcomes after AF ablation (HR, 8.66; 95% CI, 2.942–5.5; P<0.0001).Conclusions:Adverse clinical outcomes of death, HF hospitalization and AF recurrence were more frequent in patients with AF following HF than in those with AF preceding HF.
AbstractList The purpose of this study was to elucidate the effect of the temporal relationship between atrial fibrillation (AF) and heart failure (HF) on clinical outcomes after catheter ablation. We included 129 consecutive patients with AF and HF who underwent catheter ablation in hospital from December 2014 to September 2017. The patients were divided into 2 groups based on the temporal relationship between AF and HF. Group 1 consisted of 42 patients with AF following HF while Group 2 consisted of 87 patients with AF preceding HF or those who developed both of them simultaneously at the timing of first visit to a doctor. The primary endpoint was a composite of death and hospitalization due to HF during a 2-year follow-up. AF recurrence was more common in Group 1 (45% vs. 23%; hazard ratio [HR], 2.49; 95% confidence interval [CI], 1.25-4.94; P=0.009). Death and HF hospitalization were more frequent in Group 1 (19 [45%], 6 [7%] patients, respectively, P<0.0001). After adjustment for several covariates, patients in Group 1 were independently associated with poorer outcomes after AF ablation (HR, 8.66; 95% CI, 2.942-5.5; P<0.0001). Adverse clinical outcomes of death, HF hospitalization and AF recurrence were more frequent in patients with AF following HF than in those with AF preceding HF.
The purpose of this study was to elucidate the effect of the temporal relationship between atrial fibrillation (AF) and heart failure (HF) on clinical outcomes after catheter ablation.BACKGROUNDThe purpose of this study was to elucidate the effect of the temporal relationship between atrial fibrillation (AF) and heart failure (HF) on clinical outcomes after catheter ablation.We included 129 consecutive patients with AF and HF who underwent catheter ablation in hospital from December 2014 to September 2017. The patients were divided into 2 groups based on the temporal relationship between AF and HF. Group 1 consisted of 42 patients with AF following HF while Group 2 consisted of 87 patients with AF preceding HF or those who developed both of them simultaneously at the timing of first visit to a doctor. The primary endpoint was a composite of death and hospitalization due to HF during a 2-year follow-up. AF recurrence was more common in Group 1 (45% vs. 23%; hazard ratio [HR], 2.49; 95% confidence interval [CI], 1.25-4.94; P=0.009). Death and HF hospitalization were more frequent in Group 1 (19 [45%], 6 [7%] patients, respectively, P<0.0001). After adjustment for several covariates, patients in Group 1 were independently associated with poorer outcomes after AF ablation (HR, 8.66; 95% CI, 2.942-5.5; P<0.0001).METHODS AND RESULTSWe included 129 consecutive patients with AF and HF who underwent catheter ablation in hospital from December 2014 to September 2017. The patients were divided into 2 groups based on the temporal relationship between AF and HF. Group 1 consisted of 42 patients with AF following HF while Group 2 consisted of 87 patients with AF preceding HF or those who developed both of them simultaneously at the timing of first visit to a doctor. The primary endpoint was a composite of death and hospitalization due to HF during a 2-year follow-up. AF recurrence was more common in Group 1 (45% vs. 23%; hazard ratio [HR], 2.49; 95% confidence interval [CI], 1.25-4.94; P=0.009). Death and HF hospitalization were more frequent in Group 1 (19 [45%], 6 [7%] patients, respectively, P<0.0001). After adjustment for several covariates, patients in Group 1 were independently associated with poorer outcomes after AF ablation (HR, 8.66; 95% CI, 2.942-5.5; P<0.0001).Adverse clinical outcomes of death, HF hospitalization and AF recurrence were more frequent in patients with AF following HF than in those with AF preceding HF.CONCLUSIONSAdverse clinical outcomes of death, HF hospitalization and AF recurrence were more frequent in patients with AF following HF than in those with AF preceding HF.
Background:The purpose of this study was to elucidate the effect of the temporal relationship between atrial fibrillation (AF) and heart failure (HF) on clinical outcomes after catheter ablation.Methods and Results:We included 129 consecutive patients with AF and HF who underwent catheter ablation in hospital from December 2014 to September 2017. The patients were divided into 2 groups based on the temporal relationship between AF and HF. Group 1 consisted of 42 patients with AF following HF while Group 2 consisted of 87 patients with AF preceding HF or those who developed both of them simultaneously at the timing of first visit to a doctor. The primary endpoint was a composite of death and hospitalization due to HF during a 2-year follow-up. AF recurrence was more common in Group 1 (45% vs. 23%; hazard ratio [HR], 2.49; 95% confidence interval [CI], 1.25–4.94; P=0.009). Death and HF hospitalization were more frequent in Group 1 (19 [45%], 6 [7%] patients, respectively, P<0.0001). After adjustment for several covariates, patients in Group 1 were independently associated with poorer outcomes after AF ablation (HR, 8.66; 95% CI, 2.942–5.5; P<0.0001).Conclusions:Adverse clinical outcomes of death, HF hospitalization and AF recurrence were more frequent in patients with AF following HF than in those with AF preceding HF.
Author Nanto, Kiyonori
Kanda, Takashi
Okuno, Shota
Mano, Toshiaki
Tsuji, Aki
Iida, Osamu
Hata, Yosuke
Matsuda, Yasuhiro
Okamoto, Shin
Asai, Mitsutoshi
Masuda, Masaharu
Ishihara, Takayuki
Tsujimura, Takuya
Author_xml – sequence: 1
  fullname: Tsuji, Aki
  organization: Division of Internal Medicine, Moriguchi Keijinkai Hospital
– sequence: 2
  fullname: Masuda, Masaharu
  organization: Kansai Rosai Hospital Cardiovascular Center
– sequence: 3
  fullname: Asai, Mitsutoshi
  organization: Kansai Rosai Hospital Cardiovascular Center
– sequence: 4
  fullname: Iida, Osamu
  organization: Kansai Rosai Hospital Cardiovascular Center
– sequence: 5
  fullname: Okamoto, Shin
  organization: Kansai Rosai Hospital Cardiovascular Center
– sequence: 6
  fullname: Ishihara, Takayuki
  organization: Kansai Rosai Hospital Cardiovascular Center
– sequence: 7
  fullname: Nanto, Kiyonori
  organization: Kansai Rosai Hospital Cardiovascular Center
– sequence: 8
  fullname: Kanda, Takashi
  organization: Kansai Rosai Hospital Cardiovascular Center
– sequence: 9
  fullname: Tsujimura, Takuya
  organization: Kansai Rosai Hospital Cardiovascular Center
– sequence: 10
  fullname: Matsuda, Yasuhiro
  organization: Kansai Rosai Hospital Cardiovascular Center
– sequence: 11
  fullname: Okuno, Shota
  organization: Kansai Rosai Hospital Cardiovascular Center
– sequence: 12
  fullname: Hata, Yosuke
  organization: Kansai Rosai Hospital Cardiovascular Center
– sequence: 13
  fullname: Mano, Toshiaki
  organization: Kansai Rosai Hospital Cardiovascular Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32684540$$D View this record in MEDLINE/PubMed
BookMark eNpFkE1P4zAQhq0VaPna-56Qj1wCEztO42Op6EJVidUKzpZjT6irJA62K8S_35QUuIxHnmdejZ4zctT7Hgn5ncN1zgS_MS6Y7fVilTHIIJf5D3Ka82KWFRWDo4--zGRV8BNyFuMWgEkQ8ic54aysClHAKekeukGbRH1D0wbpE3aDD7ql_7DVyfk-btxAbzG9IfZ0noIbZ0tXB9dOc6p7S-9Rh0SX2rW7gHT8_Bv8S--ji3TeJAx0Xk_0BTludBvx1-E9J8_Lu6fFfbZ-_POwmK8zUzKWMqMxL-qm1MKUnFuOrAGooK5nEmoUlTUSSwu5sBLRWKsb3kBpxQxqw3gJ_JxcTblD8K87jEl1Lhocb-7R76JiBRNCilHDiMKEmuBjDNioIbhOh3eVg9pLVh-S1WKlGKi95HHl8pC-qzu0XwufVkdgOQHbmPQLfgGjJWdaPCRWhZL78p38DWx0UNjz_4XgldI
CitedBy_id crossref_primary_10_1093_eurheartj_ehad428
crossref_primary_10_1253_circj_CJ_20_0654
crossref_primary_10_1253_circj_CJ_21_0218
crossref_primary_10_1016_j_hrthm_2024_03_017
crossref_primary_10_1007_s10840_024_01771_5
crossref_primary_10_1002_ehf2_13896
crossref_primary_10_1093_europace_euae043
crossref_primary_10_1016_j_ijcard_2022_04_040
Cites_doi 10.1136/heartjnl-2016-310391
10.1161/01.CIR.0000072767.89944.6E
10.1093/eurjhf/hfp085
10.1056/NEJMoa0708789
10.1093/europace/eux119
10.1161/CIRCEP.114.001938
10.1016/j.hrthm.2017.05.012
10.1016/j.jacc.2017.02.049
10.1016/S0002-9149(02)03373-8
10.1161/CIRCULATIONAHA.108.772582
10.1016/j.amjmed.2014.06.006
10.1161/01.CIR.0000132470.78896.A8
10.1161/CIRCULATIONAHA.115.019406
10.1016/j.jchf.2019.03.005
10.1016/j.jacc.2017.08.041
10.1016/j.ccl.2019.01.001
10.1056/NEJMoa1707855
10.1016/j.hrthm.2014.03.009
ContentType Journal Article
Copyright 2020 THE JAPANESE CIRCULATION SOCIETY
Copyright_xml – notice: 2020 THE JAPANESE CIRCULATION SOCIETY
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1253/circj.CJ-20-0191
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1347-4820
EndPage 1474
ExternalDocumentID 10_1253_circj_CJ_20_0191
32684540
article_circj_84_9_84_CJ_20_0191_article_char_en
Genre Journal Article
Observational Study
GroupedDBID ---
.55
29B
2WC
53G
5GY
5RE
6J9
ACGFO
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
JSF
JSH
KQ8
M~E
OK1
P2P
RJT
RNS
RZJ
TR2
W2D
X7M
XSB
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c622t-cae14bf6a5c633d3e2f0080bb790be58dc9e6d015d9eecddaf3f06d570bc23603
ISSN 1346-9843
1347-4820
IngestDate Mon Oct 21 16:40:44 EDT 2024
Fri Aug 23 02:59:12 EDT 2024
Sat Nov 02 12:07:20 EDT 2024
Thu Aug 17 20:28:39 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Heart failure
Temporal relationship
Prognosis
Ablation
Atrial fibrillation
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c622t-cae14bf6a5c633d3e2f0080bb790be58dc9e6d015d9eecddaf3f06d570bc23603
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://www.jstage.jst.go.jp/article/circj/84/9/84_CJ-20-0191/_article/-char/en
PMID 32684540
PQID 2425595326
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2425595326
crossref_primary_10_1253_circj_CJ_20_0191
pubmed_primary_32684540
jstage_primary_article_circj_84_9_84_CJ_20_0191_article_char_en
PublicationCentury 2000
PublicationDate 2020-08-25
PublicationDateYYYYMMDD 2020-08-25
PublicationDate_xml – month: 08
  year: 2020
  text: 2020-08-25
  day: 25
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Circulation Journal
PublicationTitleAlternate Circ J
PublicationYear 2020
Publisher The Japanese Circulation Society
Publisher_xml – name: The Japanese Circulation Society
References 7. Jaïs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 study. Circulation 2008; 118: 2498–2505.
1. Cha YM, Redfield MM, Shen WK, Gersh BJ. Atrial fibrillation and ventricular dysfunction: A vicious electromechanical cycle. Circulation 2004; 109: 2839–2843.
13. Masuda M, Fujita M, Iida O, Okamoto S, Ishihara T, Nanto K, et al. An E/e’ ratio on echocardiography predicts the existence of left atrial low-voltage areas and poor outcomes after catheter ablation for atrial fibrillation. Europace 2018; 20: e60–e68.
3. Mamas MA, Caldwell JC, Chacko S, Garratt CJ, Fath-Ordoubadi F, Neyses L. A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Fail 2009; 11: 676–683.
16. Martin CA, Lambiase PD. Pathophysiology, diagnosis and treatment of tachycardiomyopathy. Heart 2017; 103: 1543–1552.
14. Aleong RG, Sauer WH, Davis G, Bristow MR. New-onset atrial fibrillation predicts heart failure progression. Am J Med 2014; 127: 963–971.
4. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003; 107: 2920–2925.
17. Mueller KAL, Heinzmann D, Klingel K, Fallier-Becker P, Kandolf R, Kilias A, et al. Histopathological and immunological characteristics of tachycardia-induced cardiomyopathy. J Am Coll Cardiol 2017; 69: 2160–2172.
18. Prabhu S, Taylor AJ, Costello BT, Kaye DM, McLellan AJA, Voskoboinik A, et al. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: The CAMERA-MRI Study. J Am Coll Cardiol 2017; 70: 1949–1961.
2. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91: 2D–8D.
12. Park J, Joung B, Uhm JS, Young Shim C, Hwang C, Hyoung Lee M, et al. High left atrial pressures are associated with advanced electroanatomical remodeling of left atrium and independent predictors for clinical recurrence of atrial fibrillation after catheter ablation. Heart Rhythm 2014; 11: 953–960.
6. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 35825: 2667–2677.
8. Anselmino M, Matta M, D’Ascenzo F, Bunch TJ, Schilling RJ, Hunter RJ, et al. Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: A systematic review and meta-analysis. Circ Arrhythm Electrophysiol 2014; 7: 1011–1018.
10. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al; CASTLE-AF Investigators. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 2018; 378: 417–427.
5. Karnik AA, Gopal DM, Ko D, Benjamin EJ, Helm RH. Epidemiology of atrial fibrillation and heart failure: A growing and important problem. Cardiol Clin 2019; 37: 119–129.
15. Carlisle MA, Fudim M, DeVore AD, Piccini JP. Heart failure and atrial fibrillation, like fire and fury. JACC Heart Fail 2019; 7: 447–456.
9. Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: Results from the AATAC Multicenter Randomized Trial. Circulation 2016; 133: 1637–1644.
11. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2017; 14: e275–e444.
32741847 - Circ J. 2020 Aug 25;84(9):1454-1455. doi: 10.1253/circj.CJ-20-0654
11
12
13
14
15
16
17
18
1
2
3
4
5
6
7
8
9
10
References_xml – ident: 16
  doi: 10.1136/heartjnl-2016-310391
– ident: 4
  doi: 10.1161/01.CIR.0000072767.89944.6E
– ident: 3
  doi: 10.1093/eurjhf/hfp085
– ident: 6
  doi: 10.1056/NEJMoa0708789
– ident: 13
  doi: 10.1093/europace/eux119
– ident: 8
  doi: 10.1161/CIRCEP.114.001938
– ident: 11
  doi: 10.1016/j.hrthm.2017.05.012
– ident: 17
  doi: 10.1016/j.jacc.2017.02.049
– ident: 2
  doi: 10.1016/S0002-9149(02)03373-8
– ident: 7
  doi: 10.1161/CIRCULATIONAHA.108.772582
– ident: 14
  doi: 10.1016/j.amjmed.2014.06.006
– ident: 1
  doi: 10.1161/01.CIR.0000132470.78896.A8
– ident: 9
  doi: 10.1161/CIRCULATIONAHA.115.019406
– ident: 15
  doi: 10.1016/j.jchf.2019.03.005
– ident: 18
  doi: 10.1016/j.jacc.2017.08.041
– ident: 5
  doi: 10.1016/j.ccl.2019.01.001
– ident: 10
  doi: 10.1056/NEJMoa1707855
– ident: 12
  doi: 10.1016/j.hrthm.2014.03.009
SSID ssj0029059
Score 2.3901255
Snippet Background:The purpose of this study was to elucidate the effect of the temporal relationship between atrial fibrillation (AF) and heart failure (HF) on...
The purpose of this study was to elucidate the effect of the temporal relationship between atrial fibrillation (AF) and heart failure (HF) on clinical outcomes...
SourceID proquest
crossref
pubmed
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 1467
SubjectTerms Ablation
Aged
Aged, 80 and over
Atrial fibrillation
Atrial Fibrillation - complications
Atrial Fibrillation - mortality
Atrial Fibrillation - surgery
Atrial Function, Left
Catheter Ablation - methods
Female
Follow-Up Studies
Heart failure
Heart Failure - complications
Heart Failure - mortality
Heart Failure - surgery
Hospitalization
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Prognosis
Proportional Hazards Models
Prospective Studies
Recurrence
Risk Factors
Stroke Volume
Temporal relationship
Treatment Outcome
Title Impact of the Temporal Relationship Between Atrial Fibrillation and Heart Failure on Prognosis After Ablation
URI https://www.jstage.jst.go.jp/article/circj/84/9/84_CJ-20-0191/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/32684540
https://www.proquest.com/docview/2425595326
Volume 84
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Circulation Journal, 2020/08/25, Vol.84(9), pp.1467-1474
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6gRAvE9fRcZGReEFVIPfET6iUVl3ZBYlO2pvl2A6kdC1qmv_P8SVOhzZpPPBiVW4cJ-d8sf35HJ-D0DvOy0DIUnokY8KL46TwWMBjz2ck4iyDGVeow8nT79nZZf5lHI97vTbvYFf3XzUNdaBrdXL2H7TtbgoV8Bt0DiVoHco76f3YHXtUS8q5iTy17JzelHPWZ-ucNTQ5OybK7X9p_tfGhCkIZTuYsEr5rCtzwrfNWjnkVfVgqHOKD4tlp9E2zkG14TYXmItHcVuQCvVoM5imVfrLwW5D60Tq9hPqZqHdDYa_qm7vvG4EM-eMavaTbRoH2trk1j6ttnWzXcOrOuBXpsV5za6a3Y2OULvZmUPRdmyO4syL89CYceQNdXZANznnLHDJzuisZoUbp41Q5_7g8LqLD6OZp_oOTBKx6xG6z87p5OLkhM7Hl_M9dC-EwU3T-OOvjuQTXyfocw9mTePQw8e_739tKXR_AWzgh7yd6OgFz_wROrBMBQ8NxB6jnlw9QQ9OrS_GU3RlkIbXJQZ14hZpeBdp2CING6ThXaRhQBrWSMMWaRgqHdKwRhpukfYMXUzG89HUs8k7PJ6G4dbjTAZxUaYs4WkUiUiGpWInRZERv5BJLjiRqYDFqCBSciFYGZV-KpLML3gYpX70HO2v1iv5AuFA8CRnuQQmDPS_gCV2LpX5MCCy9POM9NH7Vo70t4nRQhW3BZlTLXM6mtHQp0rmffTJCNpdab9Ue2UeU6KKrkV3ASAaRpg-ettqiMJQrOxr8LWsm5oq9p6QBAhRHx0a1bleIhVVCdjR0R1av0QPO_y_QvvbTSNfo71aNG801v4AGjS2sQ
link.rule.ids 315,782,786,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+the+Temporal+Relationship+Between+Atrial+Fibrillation+and+Heart+Failure+on+Prognosis+After+Ablation&rft.jtitle=Circulation+journal+%3A+official+journal+of+the+Japanese+Circulation+Society&rft.au=Tsuji%2C+Aki&rft.au=Masuda%2C+Masaharu&rft.au=Asai%2C+Mitsutoshi&rft.au=Iida%2C+Osamu&rft.date=2020-08-25&rft.issn=1347-4820&rft.eissn=1347-4820&rft.volume=84&rft.issue=9&rft.spage=1467&rft_id=info:doi/10.1253%2Fcircj.CJ-20-0191&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-9843&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-9843&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-9843&client=summon